Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 9/20 | 0.43 |
| ▸ | RARG | P13631 | 9/20 | 0.43 |
| ▸ | RARA | P10276 | 8/20 | 0.43 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 4/20 | 0.31 |
| ▸ | RXRB | P28702 | 2/20 | 0.30 |
| ▸ | RXRG | P48443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6421410 | 0.91 | RARB (0.40) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL1406466 | 0.88 | RARA (0.35) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL1406906 | 0.87 | RARB (0.38) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL6439846 | 0.87 | RARA (0.34) | RARBRARGRARA | |
| SCHEMBL1406649 | 0.85 | RARB (0.44) | RARBRARGRARARXRARXRB | |
| SCHEMBL1406658 | 0.85 | RARB (0.58) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL1406890 | 0.84 | RARB (0.45) | RARBRARGRARARXRARXRB | |
| SCHEMBL1406893 | 0.84 | RARB (0.45) | RARBRARGRARARXRARXRB | |
| SCHEMBL1406873 | 0.84 | RARB (0.45) | RARBRARGRARACYP26A1CYP3A4 | |
| SCHEMBL1406695 | 0.84 | RARB (0.60) | RARBRARGRARACYP26A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1513793-A1 | NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | Galderma Research & Development, S.N.C. (FR) | 2005-03-16 | — | — | EP | disclosed |
| WO-2003101928-A1 | NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2003-12-11 | — | — | WO | disclosed |